These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9147421)

  • 1. Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals.
    Eugen-Olsen J; Iversen AK; Garred P; Koppelhus U; Pedersen C; Benfield TL; Sorensen AM; Katzenstein T; Dickmeiss E; Gerstoft J; Skinhøj P; Svejgaard A; Nielsen JO; Hofmann B
    AIDS; 1997 Mar; 11(3):305-10. PubMed ID: 9147421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine receptor CCR2b 64I polymorphism and its relation to CD4 T-cell counts and disease progression in a Danish cohort of HIV-infected individuals. Copenhagen AIDS cohort.
    Eugen-Olsen J; Iversen AK; Benfield TL; Koppelhus U; Garred P
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun; 18(2):110-6. PubMed ID: 9637575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
    Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
    Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual effect of CCR5 delta 32 gene deletion in HIV-1-infected patients. Copenhagen AIDS Study Group.
    Garred P; Eugen-Olsen J; Iversen AK; Benfield TL; Svejgaard A; Hofmann B
    Lancet; 1997 Jun; 349(9069):1884. PubMed ID: 9217763
    [No Abstract]   [Full Text] [Related]  

  • 5. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection.
    Liu R; Paxton WA; Choe S; Ceradini D; Martin SR; Horuk R; MacDonald ME; Stuhlmann H; Koup RA; Landau NR
    Cell; 1996 Aug; 86(3):367-77. PubMed ID: 8756719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.
    Dean M; Carrington M; Winkler C; Huttley GA; Smith MW; Allikmets R; Goedert JJ; Buchbinder SP; Vittinghoff E; Gomperts E; Donfield S; Vlahov D; Kaslow R; Saah A; Rinaldo C; Detels R; O'Brien SJ
    Science; 1996 Sep; 273(5283):1856-62. PubMed ID: 8791590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient.
    Balotta C; Bagnarelli P; Violin M; Ridolfo AL; Zhou D; Berlusconi A; Corvasce S; Corbellino M; Clementi M; Clerici M; Moroni M; Galli M
    AIDS; 1997 Aug; 11(10):F67-71. PubMed ID: 9256936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk.
    Zimmerman PA; Buckler-White A; Alkhatib G; Spalding T; Kubofcik J; Combadiere C; Weissman D; Cohen O; Rubbert A; Lam G; Vaccarezza M; Kennedy PE; Kumaraswami V; Giorgi JV; Detels R; Hunter J; Chopek M; Berger EA; Fauci AS; Nutman TB; Murphy PM
    Mol Med; 1997 Jan; 3(1):23-36. PubMed ID: 9132277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.
    Samson M; Libert F; Doranz BJ; Rucker J; Liesnard C; Farber CM; Saragosti S; Lapoumeroulie C; Cognaux J; Forceille C; Muyldermans G; Verhofstede C; Burtonboy G; Georges M; Imai T; Rana S; Yi Y; Smyth RJ; Collman RG; Doms RW; Vassart G; Parmentier M
    Nature; 1996 Aug; 382(6593):722-5. PubMed ID: 8751444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group.
    Meyer L; Magierowska M; Hubert JB; Rouzioux C; Deveau C; Sanson F; Debre P; Delfraissy JF; Theodorou I
    AIDS; 1997 Sep; 11(11):F73-8. PubMed ID: 9302436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression.
    Michael NL; Chang G; Louie LG; Mascola JR; Dondero D; Birx DL; Sheppard HW
    Nat Med; 1997 Mar; 3(3):338-40. PubMed ID: 9055864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the human immunodeficiency virus type-1 coreceptors CXCR-4 (fusin, LESTR) and CKR-5 in CD34+ hematopoietic progenitor cells.
    Deichmann M; Kronenwett R; Haas R
    Blood; 1997 May; 89(10):3522-8. PubMed ID: 9160656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between CCR5 genotype and the clinical course of HIV-1 infection.
    de Roda Husman AM; Koot M; Cornelissen M; Keet IP; Brouwer M; Broersen SM; Bakker M; Roos MT; Prins M; de Wolf F; Coutinho RA; Miedema F; Goudsmit J; Schuitemaker H
    Ann Intern Med; 1997 Nov; 127(10):882-90. PubMed ID: 9382366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased frequency of CCR-5 delta 32 heterozygotes among long-term non-progressors with HIV-1 infection. The Australian Long-Term Non-Progressor Study Group.
    Stewart GJ; Ashton LJ; Biti RA; Ffrench RA; Bennetts BH; Newcombe NR; Benson EM; Carr A; Cooper DA; Kaldor JM
    AIDS; 1997 Dec; 11(15):1833-8. PubMed ID: 9412701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of effect of chemokine receptor CCR2b gene polymorphism (64I) on HIV-1 plasma RNA viral load and immune activation among HIV-1 seropositive female workers in Abidjan, Côte d'Ivoire.
    Adjé CA; Bilé CE; Kestens L; Koblavi-Deme S; Ghys PD; Maurice C; Kalou-Badirou M; Kabran N; Ekpini RE; Roels TH; Wiktor SZ; Nkengasong JN
    J Med Virol; 2001 Aug; 64(4):398-401. PubMed ID: 11468722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 infection in a man homozygous for CCR5 delta 32.
    O'Brien TR; Winkler C; Dean M; Nelson JA; Carrington M; Michael NL; White GC
    Lancet; 1997 Apr; 349(9060):1219. PubMed ID: 9130945
    [No Abstract]   [Full Text] [Related]  

  • 17. Low HIV-1 proviral DNA burden detected by negative polymerase chain reaction in seropositive individuals correlates with slower disease progression.
    Schechter MT; Neumann PW; Weaver MS; Montaner JS; Cassol SA; Le TN; Craib KJ; O'Shaughnessy MV
    AIDS; 1991 Apr; 5(4):373-9. PubMed ID: 1676280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of a CCR5 gene 32-bp deletion in an Israeli cohort of HIV-1-infected and uninfected hemophilia patients.
    Kantor R; Barzilai A; Varon D; Martinowitz U; Gershoni JM
    J Hum Virol; 1998; 1(4):299-301. PubMed ID: 10195255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR5 chemokine receptor genotype frequencies among Puerto Rican HIV-1-seropositive individuals.
    Gonzalez S; Tirado G; Revuelta G; Yamamura Y; Lu Y; Nerurkar VR; Yanagihara R
    Bol Asoc Med P R; 1998; 90(1-3):12-5. PubMed ID: 9734151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 infection in an individual homozygous for CCR5 delta 32. Seroco Study Group.
    Theodorou I; Meyer L; Magierowska M; Katlama C; Rouzioux C
    Lancet; 1997 Apr; 349(9060):1219-20. PubMed ID: 9130946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.